evaluating Nexavar

Related by string. * Evaluated . EVALUATING . EVALUATED . evaluated . Evaluating : evaluating CK # . When evaluating Antigenics . rigorously evaluated . Intervention Trial Evaluating . evaluating OGX . prospectively evaluated . evaluating ispinesib / : Beyond Nexavar Onyx . Nexavar sorafenib tablets . preclinical studies Nexavar . sorafenib Nexavar R . sorafenib Nexavar . Nexavar sorafenib * *

Related by context. Frequent words. (Click for all words.) 67 pertuzumab 66 deforolimus 63 HER2 positive metastatic breast 63 Phase 1b trial 62 axitinib 61 randomized Phase III 61 registrational trial 61 NSABP 60 phase IIb clinical 60 elotuzumab 60 R sorafenib tablets 60 Phase Ib clinical 60 relapsed multiple myeloma 59 relapsed refractory multiple myeloma 59 ZD# [001] 59 placebo controlled clinical 59 SWOG 59 Cloretazine R VNP#M 59 IRESSA 58 phase IIa 58 tanespimycin 58 phase IIb 58 Phase 2a trial 58 ocrelizumab 58 KRN# 58 Diamyd ® 58 temsirolimus 58 heavily pretreated 58 figitumumab 57 palifosfamide 57 Amrubicin 57 bevacizumab Avastin 57 CR# vcMMAE 57 decitabine 57 neoadjuvant 57 adecatumumab 57 ASA# 57 RGB # 57 confirmatory Phase III 57 TORISEL 57 Irinotecan 57 Phase 2b clinical 57 Panzem R 57 Taxotere ® 57 HGS ETR1 57 TRISENOX 57 Phase Ib 57 double blinded placebo 57 pazopanib 56 Phase 2b study 56 Phase 1b clinical 56 Pirfenidone 56 registrational 56 Allovectin 7 R 56 diabetic neuropathic pain 56 Phase 1b 56 placebo controlled Phase 56 BAY #-# 56 Gynecologic Oncology Group 56 goserelin 56 cutaneous T cell 56 metastatic renal cell carcinoma 56 Phase 2a clinical 56 custirsen 56 cangrelor 56 mRCC 56 talactoferrin 56 CoFactor 56 IMC A# 56 Azedra 55 celgosivir 55 vandetanib 55 talabostat 55 PXD# 55 recurrent ovarian cancer 55 rNAPc2 55 Pivotal Phase 55 GLPG# 55 Phase 2b trial 55 Phase IIb clinical 55 Mipomersen 55 castration resistant prostate cancer 55 Carfilzomib 55 Amigal 55 squalamine 55 senicapoc 55 RRMS patients 55 carboplatin paclitaxel 55 mTOR inhibitor 55 dose escalation trial 55 subgroup analyzes 54 nab paclitaxel 54 PREZISTA r 54 GSK# [001] 54 pemetrexed 54 DDP# 54 Zolinza 54 patients undergoing percutaneous 54 BCX# 54 Urocidin 54 abiraterone acetate

Back to home page